Recurrence of primary cutaneous CD30-positive lymphoproliferative disorder following COVID-19 vaccination

被引:29
作者
Brumfiel, Caitlin M. [1 ]
Patel, Meera H. [1 ]
DiCaudo, David J. [1 ]
Rosenthal, Allison C. [2 ]
Pittelkow, Mark R. [1 ]
Mangold, Aaron R. [1 ]
机构
[1] Mayo Clin Arizona, Dept Dermatol, 13400 East Shea Blvd, Scottsdale, AZ 85259 USA
[2] Div Hematol Oncol, Dept Med, Phoenix, AZ USA
关键词
Lymphoma; lymphoproliferative disorder; CD30-positive lymphoproliferative disorder; COVID-19; vaccination; vaccine; mRNA vaccine;
D O I
10.1080/10428194.2021.1924371
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:2554 / 2555
页数:2
相关论文
共 4 条
[1]  
Centers for Disease Control and prevention, LOC REACT SYST REACT
[2]  
National Comprehensive Cancer Network, PRIM CUT LYMPH VERS
[3]   Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine [J].
Polack, Fernando P. ;
Thomas, Stephen J. ;
Kitchin, Nicholas ;
Absalon, Judith ;
Gurtman, Alejandra ;
Lockhart, Stephen ;
Perez, John L. ;
Perez Marc, Gonzalo ;
Moreira, Edson D. ;
Zerbini, Cristiano ;
Bailey, Ruth ;
Swanson, Kena A. ;
Roychoudhury, Satrajit ;
Koury, Kenneth ;
Li, Ping ;
Kalina, Warren V. ;
Cooper, David ;
Frenck, Robert W., Jr. ;
Hammitt, Laura L. ;
Tureci, Ozlem ;
Nell, Haylene ;
Schaefer, Axel ;
Unal, Serhat ;
Tresnan, Dina B. ;
Mather, Susan ;
Dormitzer, Philip R. ;
Sahin, Ugur ;
Jansen, Kathrin U. ;
Gruber, William C. .
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (27) :2603-2615
[4]  
The National Comprehensive Cancer Network, 2021, NCCN CANC COVID 19 V